Answers are grounded in this paper and cite their sources.
The study reports prevalence and antifungal susceptibility of rare yeasts in bloodstream infections, highlighting the need for better diagnosis and treatment.
This study provides valuable insights into the prevalence rates, species distribution and antifungal susceptibility of rare yeasts causing BSIs in tertiary care hospitals. Our findings highlight the need for continuous surveillance, incorporation of new diagnostic and tailored therapeutic strategies to mitigate morbidity and mortality due to invasive infections caused by emerging fungal pathogens.
No takes yet. Share an insight, caveat, or question.
Buonafine et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: